RMD
Income statement / Annual
Last year (2024), ResMed Inc.'s total revenue was $4.69 B,
an increase of 10.95% from the previous year.
In 2024, ResMed Inc.'s net income was $1.02 B.
See ResMed Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$4.69 B
|
$4.22 B
|
$3.58 B
|
$3.20 B
|
$2.96 B
|
$2.61 B
|
$2.34 B
|
$2.07 B
|
$1.84 B
|
$1.68 B
|
| Cost of Revenue |
$2.08 B |
$1.87 B |
$1.55 B |
$1.36 B |
$1.24 B |
$1.07 B |
$978.03 M |
$864.99 M |
$772.22 M |
$667.52 M |
| Gross Profit |
$2.61 B |
$2.36 B |
$2.02 B |
$1.84 B |
$1.72 B |
$1.54 B |
$1.36 B |
$1.20 B |
$1.07 B |
$1.01 B |
| Gross Profit Ratio |
0.56 |
0.56 |
0.57 |
0.58 |
0.58 |
0.59 |
0.58 |
0.58 |
0.58 |
0.6 |
| Research and Development
Expenses |
$307.53 M
|
$287.64 M
|
$253.58 M
|
$225.28 M
|
$201.95 M
|
$180.65 M
|
$155.15 M
|
$144.47 M
|
$118.65 M
|
$114.87 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$600.37 M
|
$553.97 M
|
$488.06 M
|
$478.63 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$5.46 M
|
-$6.00 M
|
| Selling, General &
Administrative Expenses |
$917.14 M
|
$874.00 M
|
$739.37 M
|
$670.39 M
|
$676.69 M
|
$645.01 M
|
$600.37 M
|
$553.97 M
|
$482.59 M
|
$472.63 M
|
| Other Expenses |
$143.71 M |
-$5.71 M |
$31.08 M |
$31.08 M |
$30.09 M |
$74.94 M |
-$8.54 M |
$4.10 M |
$4.96 M |
$6.25 M |
| Operating Expenses |
$1.37 B |
$1.20 B |
$1.02 B |
$926.75 M |
$908.73 M |
$900.60 M |
$801.90 M |
$745.01 M |
$625.17 M |
$596.16 M |
| Cost And Expenses |
$3.37 B |
$3.07 B |
$2.58 B |
$2.28 B |
$2.15 B |
$1.97 B |
$1.78 B |
$1.61 B |
$1.40 B |
$1.26 B |
| Interest Income |
$0.00 |
$47.38 M |
$22.31 M |
$362,000.00 |
$1.02 M |
$2.30 M |
$16.38 M |
$17.09 M |
$16.86 M |
$26.21 M |
| Interest Expense |
$45.71 M |
$47.38 M |
$22.31 M |
$23.99 M |
$40.38 M |
$36.16 M |
$28.36 M |
$28.24 M |
$11.21 M |
$5.78 M |
| Depreciation &
Amortization |
$216.21 M
|
$196.52 M
|
$193.84 M
|
$191.52 M
|
$181.37 M
|
$150.80 M
|
$119.96 M
|
$112.16 M
|
$86.85 M
|
$73.06 M
|
| EBITDA |
$1.60 B
|
$1.36 B
|
$1.18 B
|
$1.10 B
|
$990.43 M
|
$705.80 M
|
$680.22 M
|
$568.89 M
|
$522.72 M
|
$482.29 M
|
| EBITDA Ratio |
0.34 |
0.32 |
0.33 |
0.35 |
0.33 |
0.32 |
0.3 |
0.29 |
0.29 |
0.29 |
| Operating Income Ratio
|
0.28
|
0.27
|
0.28
|
0.28
|
0.27
|
0.22
|
0.23
|
0.21
|
0.23
|
0.24
|
| Total Other
Income/Expenses Net |
-$55.10 M
|
-$30.21 M
|
-$39.80 M
|
-$20.02 M
|
-$76.57 M
|
-$60.42 M
|
-$20.52 M
|
-$7.06 M
|
$10.61 M
|
$26.68 M
|
| Income Before Tax |
$1.26 B |
$1.10 B |
$960.48 M |
$883.66 M |
$733.09 M |
$518.85 M |
$521.31 M |
$418.74 M |
$439.57 M |
$435.92 M |
| Income Before Tax Ratio
|
0.27
|
0.26
|
0.27
|
0.28
|
0.25
|
0.2
|
0.22
|
0.2
|
0.24
|
0.26
|
| Income Tax Expense |
$243.85 M |
$204.11 M |
$181.05 M |
$409.16 M |
$111.41 M |
$114.26 M |
$205.72 M |
$76.46 M |
$87.16 M |
$83.03 M |
| Net Income |
$1.02 B |
$897.56 M |
$779.44 M |
$474.51 M |
$621.67 M |
$404.59 M |
$315.59 M |
$342.28 M |
$352.41 M |
$352.89 M |
| Net Income Ratio |
0.22 |
0.21 |
0.22 |
0.15 |
0.21 |
0.16 |
0.13 |
0.17 |
0.19 |
0.21 |
| EPS |
6.94 |
6.12 |
5.34 |
3.27 |
4.31 |
2.83 |
2.21 |
2.42 |
2.51 |
2.51 |
| EPS Diluted |
6.92 |
6.09 |
5.3 |
3.24 |
4.27 |
2.8 |
2.19 |
2.4 |
2.49 |
2.47 |
| Weighted Average Shares
Out |
$147.02 M
|
$146.77 M
|
$146.07 M
|
$145.31 M
|
$144.34 M
|
$143.11 M
|
$142.76 M
|
$141.36 M
|
$140.24 M
|
$140.47 M
|
| Weighted Average Shares
Out Diluted |
$147.55 M
|
$147.46 M
|
$147.04 M
|
$146.45 M
|
$145.65 M
|
$144.48 M
|
$143.99 M
|
$142.45 M
|
$141.67 M
|
$142.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
